FDA-2026-P-8053

Requests that the FDA amend and supplement the existing special control for tracheal prostheses under 21 CFR 878.3720 (Tracheal Prosthesis, Product Code NWA), so that it addresses a surface-quality risk specific to the way 3D printing is presently used to manufacture these devices